Daneng Li, MD, of City of Hope talks about research presented at the North American Neuroendocrine Tumor Society (NANETS) 2025 meeting.

The researchers proposed adopting a standardized framework that would outline the core elements needed for informed decision-making across cancer types.

Cancer surgery among patients older than 65 years is complex with high morbidity underscoring the need for specialized care at high-quality hospitals.

No differences seen among one-, two-, and three-year interval cancer predictions, age quartiles, or breast densities.

ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.